R01EY028554
Project Grant
Overview
Grant Description
Mitochondrial defects in the retinal pigment epithelium and the CFH risk allele for age-related macular degeneration.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Pasadena,
California
911033534
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 03/31/22 to 06/30/26 and the total obligations have increased 748% from $452,234 to $3,834,074.
Doheny Eye Institute was awarded
Project Grant R01EY028554
worth $3,834,074
from National Eye Institute in April 2018 with work to be completed primarily in Pasadena California United States.
The grant
has a duration of 8 years 2 months and
was awarded through assistance program 93.867 Vision Research.
The Project Grant was awarded through grant opportunity NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 7/5/24
Period of Performance
4/1/18
Start Date
6/30/26
End Date
Funding Split
$3.8M
Federal Obligation
$0.0
Non-Federal Obligation
$3.8M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for R01EY028554
Transaction History
Modifications to R01EY028554
Additional Detail
Award ID FAIN
R01EY028554
SAI Number
R01EY028554-1680330615
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NW00 NIH NATIONAL EYE INSTITUTE
Funding Office
75NW00 NIH NATIONAL EYE INSTITUTE
Awardee UEI
YM8RKEGJ5UN1
Awardee CAGE
1WH46
Performance District
CA-30
Senators
Dianne Feinstein
Alejandro Padilla
Alejandro Padilla
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Eye Institute, National Institutes of Health, Health and Human Services (075-0887) | Health research and training | Grants, subsidies, and contributions (41.0) | $3,551,984 | 100% |
Modified: 7/5/24